rs5085 — APOA2 APOA2 rs5085

APOA2 rs5085 — The Saturated Fat Sensitivity Gene

Apolipoprotein A-II (APOA2) is the second most abundant protein on HDL cholesterol particles. Beyond its role in lipid transport, research over the past two decades has revealed a surprising function: APOA2 appears to act as a satiety signal¹¹ satiety signal
APOA2 may regulate appetite for fat-rich foods by signaling fullness after a meal, analogous to apolipoprotein A-IV which is a well-established gastrointestinal satiety peptide, particularly in the context of saturated fat ingestion.

The rs5085 variant sits in intron 3 of APOA2 and is a HapMap tag SNP in strong linkage disequilibrium with the functional −265T>C promoter variant (rs5082), which reduces basal APOA2 transcription by approximately 30%. Genotyping rs5085 captures the same gene-diet signal, making it the identifier used in consumer genomics platforms while rs5082 is the molecular mechanism. The G allele at rs5085 tags the same haplotype as the C allele at rs5082 — the low-expressors.

The Mechanism

On a high saturated fat diet, individuals who carry the G allele (tagging the low-APOA2-expression haplotype) produce less apolipoprotein A-II protein. Lower circulating APOA2 is thought to blunt the postprandial satiety signal, increasing appetite particularly for fat-rich foods. This creates a vicious cycle: the variant reduces satiety, increasing fat consumption, which further suppresses APOA2 expression through an epigenetic mechanism.

A 2019 epigenomics and metabolomics study²² A 2019 epigenomics and metabolomics study
Corella et al. Epigenomics and metabolomics reveal the mechanism of the APOA2-saturated fat intake interaction affecting obesity. Am J Clin Nutr, 2019 found that high saturated fat intake drives differential DNA methylation at a CpG site (cg04436964) in the APOA2 regulatory region — but only in GG/CC-genotype carriers (the low expressors). This methylation change further suppresses APOA2 transcription and disrupts branched-chain amino acid (BCAA)³³ branched-chain amino acid (BCAA)
BCAAs include leucine, isoleucine, and valine — their catabolism is linked to insulin sensitivity and appetite regulation through mTOR signaling and tryptophan metabolic pathways, which are both involved in appetite regulation and satiety signaling.

The Evidence

The gene-diet interaction was first reported and then definitively replicated in a landmark 2009 study by Corella et al.⁴⁴ Corella et al.
Corella et al. APOA2, Dietary Fat and Body Mass Index: Replication of a Gene-Diet Interaction in Three Independent Populations. Arch Intern Med, 2009 in 3,462 subjects across three independent U.S. populations (Framingham, GOLDN, and Boston Puerto Rican studies). The critical finding: homozygous G-allele carriers (equivalent to CC at rs5082) consuming ≥22 g/day of saturated fat had 6.2% higher BMI (range 4.3–7.9%) and an odds ratio of 1.84 (95% CI: 1.38–2.47) for obesity compared to T-allele carriers. Below 22 g/day saturated fat, the association disappeared entirely (OR = 0.81, P = 0.18).

A subsequent replication⁵⁵ A subsequent replication
Corella et al. Association between the APOA2 promoter polymorphism and body weight in Mediterranean and Asian populations. Int J Obes, 2010 confirmed the interaction in Mediterranean (n=907, PREDIMED study) and Asian populations (n=3,695, Singapore National Health Survey). In Asian Indian subjects with high saturated fat intake, the obesity odds ratio for CC homozygotes reached 4.83 (95% CI: 1.17–19.94).

Behavioral data add a mechanistic layer: Smith et al.⁶⁶ Smith et al.
Smith et al. Apolipoprotein A-II polymorphism: relationships to behavioural and hormonal mediators of obesity. Int J Obes, 2011 found that GG carriers (n=1,225) consume approximately 200 more calories per day, are twice as likely to skip meals (OR=2.09), less likely to plan meals in advance, and show greater waist circumference on high saturated fat diets. A dairy-interaction study⁷⁷ dairy-interaction study
Smith et al. Apolipoprotein A2 Polymorphism Interacts with Intakes of Dairy Foods to Influence Body Weight in 2 U.S. Populations. J Nutr, 2013 in two U.S. populations linked GG genotype to greater BMI specifically with higher-fat dairy intake (P-interaction = 0.001–0.028).

The most recent evidence comes from the DIETFITS randomized trial (Lai et al., 2025, n=609)⁸⁸ (Lai et al., 2025, n=609)
Lai et al. Differential weight-loss responses of APOA2 genotype carriers to low-carbohydrate and low-fat diets: the DIETFITS trial. Obesity, 2025, which found that APOA2 T-allele homozygotes (low-risk genotype equivalent) lost significantly more weight on a low-carbohydrate/higher-SFA diet compared to a low-fat diet, while GG carriers showed no sustained advantage — consistent with the prediction that keeping saturated fat low neutralizes the genotype effect.

Practical Actions

The dietary threshold is well-defined: 22 grams of saturated fat per day is the inflection point above which the G allele produces meaningful weight and metabolic effects. For reference, a typical Western diet provides 30–40 g/day saturated fat, and 22 g corresponds to roughly 10% of energy in a 2,000 kcal/day diet — the upper limit recommended by most cardiovascular guidelines.

GG homozygotes should prioritize limiting saturated fat: replace butter, full-fat dairy, and fatty red meat with olive oil, avocado, legumes, fish, and lower-fat dairy. Monitoring total saturated fat intake (food label reading, diet tracking) is especially useful since the behavioral data suggest GG carriers have reduced awareness of intake.

Interactions

The APOA2 saturated fat interaction compounds with APOE genotype (rs429358, rs7412). Carrying both the APOA2 G allele and APOE E4 creates additive pressure to limit saturated fat: APOE E4 raises LDL cholesterol response to saturated fat, while APOA2 GG increases energy intake and BMI on high-SFA diets. The combined recommendation — strict saturated fat limitation — is reinforced by both mechanisms.